Death threats after a trial on chloroquine for COVID-19.
作者信息
Ektorp Estella
出版信息
Lancet Infect Dis. 2020 Jun;20(6):661. doi: 10.1016/S1473-3099(20)30383-2.
Abstract
摘要
相似文献
1
Death threats after a trial on chloroquine for COVID-19.
Lancet Infect Dis. 2020 Jun;20(6):661. doi: 10.1016/S1473-3099(20)30383-2.
2
Chloroquine and COVID-19, where do we stand?
Med Mal Infect. 2020 May;50(3):229-230. doi: 10.1016/j.medmal.2020.03.004. Epub 2020 Mar 27.
3
Of chloroquine and COVID-19.
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
4
Combating COVID-19 with Chloroquine.
J Mol Cell Biol. 2020 May 18;12(4):249-250. doi: 10.1093/jmcb/mjaa015.
5
Treating COVID-19 with Chloroquine.
J Mol Cell Biol. 2020 May 18;12(4):322-325. doi: 10.1093/jmcb/mjaa014.
6
[Chloroquine as a possible treatment for COVID-19].
Ned Tijdschr Geneeskd. 2020 Mar 11;164:D4936.
7
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27.
8
[Not Available].
Rev Med Suisse. 2020 Mar 11;16(685):510-511.
9
Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes.
Rev Soc Bras Med Trop. 2020 Apr 6;53:e20200155. doi: 10.1590/0037-8682-0155-2020. eCollection 2020.
10
The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene.
Clin Chem Lab Med. 2020 Jun 25;58(7):1162-1164. doi: 10.1515/cclm-2020-0442.
引用本文的文献
1
[Under a pestilent land of lies: misinformation and denialism in the smallpox epidemic in Ceará, Brazil, 1900-1905, and the covid-19 pandemic in Brazil, 2020-2022].
Hist Cienc Saude Manguinhos. 2024 Dec 16;31:e2024061. doi: 10.1590/S0104-59702024000100061. eCollection 2024.
2
Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials.
Biomedicines. 2024 Sep 27;12(10):2206. doi: 10.3390/biomedicines12102206.
3
A beta regression analysis of COVID-19 mortality in Brazil.
Infect Dis Model. 2023 Jun;8(2):309-317. doi: 10.1016/j.idm.2023.02.005. Epub 2023 Mar 7.
4
Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers.
Stem Cell Rev Rep. 2023 Feb;19(2):568-572. doi: 10.1007/s12015-022-10465-2. Epub 2022 Oct 26.
5
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19.
Mol Biomed. 2021;2(1):1. doi: 10.1186/s43556-020-00015-y. Epub 2021 Jan 20.
6
How Brazil's President turned the country into a global epicenter of COVID-19.
J Public Health Policy. 2021 Sep;42(3):439-451. doi: 10.1057/s41271-021-00302-0. Epub 2021 Aug 27.
7
Current Strategies of Antiviral Drug Discovery for COVID-19.
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
8
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30.
9
Cyber harassment of female scientists will not be the new norm.
Lancet Infect Dis. 2021 Apr;21(4):457-458. doi: 10.1016/S1473-3099(20)30944-0. Epub 2020 Dec 24.
10
The Danger of Misinformation in the COVID-19 Crisis.
Mo Med. 2020 Nov-Dec;117(6):510-512.
Zotero 插件